BioMed - Biotechnologies and advanced medical technologies
|
The programme BioMed - "Biotechnologies and advanced medical technologies" in this field is to conduct research in the area of three priorities, including the use of bionanomaterials in therapy and diagnostics, the formulation of new drugs and their functional forms as well as research into new diagnostics strategies for diseases prevention and treatment purposes. Research conducted by us concentrates on therapy of civilization diseases by obtaining innovative anti-carcinogenic and anti-osteoporosis drugs, identification of hallucinogenic substances, diagnostics and prevention of bacterial diseases, research into biodegradable polymers for the production of drugs and their application in surgery and prosthetics as well as obtaining a new generation of vaccines and antibiotics based on new chemical compounds. An interesting and unique specialty of Wrocław is the so-called issue of phage therapies used more often in cases of ineffective antibiotic treatment.
Preliminary financing of the programme is covered by EU structural funds granted in the years 2009-2014 amounting to Euro 27.6 million, implemented by the EIT+ Wrocław Research Centre.
Priority I. Use of new bionanomaterials in therapy and diagnostics
Task I.1. Synthesis and characterization of bionanomaterials for specific medical applications (Leader Ph.D., Professor Jacek Otlewski)
Task I.2. Identification of hallucinogenic substances (Ph.D., Professor Piotr Wieczorek)
Task I.3. Identification of molecular markers of diseases related to nuclear receptors dysfunction and implementation in diagnostics (Ph.D. Ewa Marcinkowska)
Priority II. New drugs and their functional forms
Task II.1. New hemiaminals-based antibiotics (Leader Ph.D., Professor Leszek Z. Ciunik)
Task II.2. Civilization diseases therapy – innovative anti-carcinogenic and anti-osteoporosis drugs (Leader Ph.D., Zdzisław Kiełbowicz)
Task II.3. Supramolecular forms of bioactive substances – from draft to the product (Leader Ph.D., Professor Aleksander Sikorski)
Task II.4. Nanoencapsulation of pharmaceuticals (Leader Ph.D., Professor Andrzej Gamian)
Task II.5. Biodegradeable polymers for production of drugs and application in surgery and prosthetics (Leader Ph.D., Professor Piotr Sobota)
Task II.6. Functions of new molecular modelling techniques supporting reasonable design of inhibitors, biocatalisators or molecular switches.
Task II.7. RNA catalytic activity modulation. HDV ribozymes as a potential aim of anti-virus therapy and useful biosensors (Leader Ph.D., Professor M. Jeżowska-Bojczuk)
Priority III. New strategies of diagnostics, prevention and cure of bacterial diseases
Task III.1. Mechanisms of replication and segregation of bacterial chromosomes – research into new aims in therapy directed against specified pathogens, Helicobacter pylori and Mycobacterium tuberculosis (Leader Ph.D., Professor Jolanta Zakrzewska-Czerwińska)
Task III.2. A new generation of anti-bacterial vaccines: synthesis, immunochemical characteristics, protective features (Leader Ph.D., Professor Czesław Ługowski)
Task III.3. Employment of ferrum and haem assimilation by Porphyromonas gingivalis bacteria in the prevention and treatment of periodontopathy (Leader Ph.D., Teresa Olczak)
Task III.4. Diagnostics and prevention of bacterial diseases (Leader Ph.D., Professor Andrzej Gamian)
Task III.5. Advanced diagnostics of neoplastic diseases (Leader Ph.D., Professor Piotr Dzięgiel)
Research and development is characteristic of the project. It features a very high level of development of proposed technological solutions. Specific solutions worked out within implementation of the project can be regularly developed as available technological solutions or products. The commercialisation of research results is planned as well.
More details of the project are available on: www.biomed.eitplus.pl
Ph.D., Professor Piotr Wieczorek
Wysłanie maila oznacza zgodę z regulaminem
